High growth, 2.5M EBITDA company, specializing in development of and MSO support for substance use disorder (SUD) / dual-diagnosis treatment facilities. Recurring portion of the business growing quickly. Independent sponsor deal with search fund investment structure. Seller staying on and rolling significant equity. Final gap of ~$4M remaining. New potential investors must have efficient decision-making cycle, as we are set to close in###-###-#### Two experienced operators on team joining the company full-time post-close. Let us know if you want to get up to speed.